Dear Editor, I read with great interest the research article by Akpinar et al. about plateletcrit (PCT) and red cell distribution width parameters in patients with slow coronary flow [1] . I would like to comment on this study.
Firstly, determinations of complete blood count were performed using a Beckman Coulter LH 780 analyzer (Beckman Coulter, Brea, CA, USA) in this study. According to the operator's guide for this analyzer, PCT and platelet distribution width (PDW) parameters are derived parameters and are for research use only. They should not be used in diagnostic procedures. Mean platelet volume (MPV) is measured directly from analysis of the platelet distribution curve and PCT is calculated according to the formula: PCT = platelet count × MPV/10,000. Therefore, reliability of PCT parameter is directly related to MPV parameter. Accurate measurements of platelet count and size are important for diagnostic, therapeutic, and research purposes. Lancé et al. reviewed the preanalytical variability of the MPV and proposed a possible approach to standardization [2] . MPV is not a routine part of the complete blood count because of ethylenediaminetetraacetic acid (EDTA)-induced changes over time. EDTA-induced platelet shape changes result in a progressive increase in MPV with impedance technology. MPV increases up to 30% within 5 min of exposure and increases further by 10-15% over the next 2 h [3] . Lancé et al. performed a study to standardize the measurement of MPV. They suggested that timing is important when measuring the MPV and that the optimal measurement time should be 120 min after venipuncture [4] . The MPV measurement time was not defined in this retrospective study.
Furthermore, a cut-off value should not be defined for PCT because different technologies for measuring the MPV yield different results. The platelet parameters derived by the automated cell counter are highly specific to the individual technologies developed for each type of analyzer. Studies comparing results from these instruments have shown MPV differences of up to 40%.
Finally, the authors concluded that increased PCT might be used as a marker for more aggressive antiplatelet treatment in patients with slow coronary flow. Platelet parameters are not used as platelet function tests. Light transmission turbidometric platelet aggregometry is the current "gold standard" test of platelet function. Beyan et al. did not observe any correlation between platelet indices measured including platelet count, MPV, PDW, PCT, and platelet aggregation responses with collagen, adenosine diphosphate, and epinephrine obtained with light transmission turbidometric platelet aggregometry in healthy subjects [5] .
In conclusion, PCT or other platelet parameters may not be useful predictors in patients with slow coronary flow.
